IDiyas

For the Inventor, By the Inventor

Kenilworth, NJ, United States of America

Ian W Davies

USPTO Granted Patents = 25


 

Average Co-Inventor Count = 6.1

ph-index = 5

Forward Citations = 127(Granted Patents)


Location History:

  • Kenilworth, NJ (US) (2016)
  • Princeton, NJ (US) (2000 - 2019)

Company Filing History:

goldMedal11 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal10 out of 4,770 
 
Merck + Co., Inc.
 patents
bronzeMedal2 out of 138 
 
Sirna Therapeutics, Inc.
 patents
4. 2 out of 832,680 
Other
 patents

Years Active: 2000-2019

Loading Chart...
Loading Chart...
Loading Chart...
25 patents (USPTO):
1. 10208064 - Inhibitors of the renal outer medullary potassium channel (2019-02-19),
2. 10131674 - Process for preparing Substituted Indole Compounds (2018-11-20),
3. 9926317 - Inhibitors of the renal outer medullary potassium channel (2018-03-27),
4. 9765107 - Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2017-09-19),
5. 9732111 - 2'-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2017-08-15),
6. 9512426 - Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications (2016-12-06),
7. 9457039 - 2'-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2016-10-04),
8. 9242988 - 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2016-01-26),
9. 9156872 - 2'-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2015-10-13),
10. 9150603 - 2'-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases (2015-10-06),
11. 9061041 - 2'-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2015-06-23),
12. 8877439 - Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications (2014-11-04),
13. 7718796 - Process for the preparation of caprolactam CGRP antagonist (2010-05-18),
14. 6800647 - 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3]bipyridinyl in pure crystalline form and process for synthesis (2004-10-05),
15. 6673935 - 5-chloro-3-(4-methanesulfonylphenyl)-6′-methyl-[2,3′]bipyridinyl in pure crystalline form and process for synthesis (2004-01-06),

Title: Ian W Davies: Pioneering Inventor in Biomedical Innovation

Introduction:

Ian W Davies, a resident of Kenilworth, NJ, USA, has distinguished himself as a visionary inventor with a remarkable portfolio of 25 patents. His dedication to creativity and unwavering perseverance have led to groundbreaking innovations in the field of biomedical sciences.

Latest Patents:

Among his latest patents is the development of inhibitors of the renal outer medullary potassium channel (ROMK) to address various medical conditions such as hypertension, heart failure, and chronic kidney disease. Additionally, his process for preparing Substituted Indole Compounds stands as a pivotal contribution to the synthesis of inhibitors for treating HCV NS5A.

Career Highlights:

Ian W Davies has significantly contributed to the research and development endeavors of acclaimed companies like Merck Sharp & Dohme Corporation and Merck & Company, Inc. His expertise and innovative spirit have shaped cutting-edge solutions in the pharmaceutical industry, making him a trailblazer in biomedical innovation.

Collaborations:

Throughout his career, Ian W Davies has collaborated with esteemed professionals such as Vinay M Girijavallabhan and Stephane L Bogen. These collaborations have fostered synergy in research efforts, leading to the successful implementation of transformative inventions in the realm of biomedical sciences.

Conclusion:

Ian W Davies' legacy as a pioneering inventor underscores the transformative power of creativity and perseverance in driving impactful change through innovation. His commitment to advancing biomedical research has not only revolutionized the field but also paved the way for groundbreaking treatments for a myriad of medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…